Phase 2 study of anastrozole in patients with estrogen receptor/progesterone receptor positive recurrent low-grade endometrial stromal sarcomas: The PARAGON trial (ANZGOG 0903)
Michael Friedländer, Charlotte Benson, Rachel O’Connell, Nicholas Reed, Andrew R. Clamp, Rosemary Lord, David Millan, Steven Nottley, Frédéric Amant, Christopher Steer, Anjana Anand, Linda Mileshkin, Philip Beale, Susana Banerjee, Nathan Bradshaw, Caroline Kelly, Karen Carty, Laura Divers, Laura E. Crotty Alexander, Richard J. Edmondson
Topics & Concepts
MedicineAnastrozoleInternal medicineClinical endpointAdverse effectAromatase inhibitorProgesterone receptorProgressive diseaseOncologyPhases of clinical researchEstrogen receptorGastroenterologyClinical trialGynecologyAromataseChemotherapyCancerBreast cancerUterine Myomas and TreatmentsEndometrial and Cervical Cancer TreatmentsSarcoma Diagnosis and Treatment